Intermittent Fasting: Myths, Fakes and Truth on This Dietary Regimen Approach.
Simone BrogiRita TabanelliSara PucaVincenzo CalderonePublished in: Foods (Basel, Switzerland) (2024)
Intermittent fasting (IF) has been indicated as a valuable alternative to the classical caloric restriction dietary regimen for lowering body weight and preventing obesity-related complications, such as metabolic syndrome and type II diabetes. However, is it effective? In this review article, we analyzed over 50 clinical studies in which IF, conducted by alternate day fasting (ADF) or time-restricted feeding (TRF), was compared with the caloric restriction approach. We evaluated the different roles of IF in treating and preventing human disorders such as metabolic syndrome, type II diabetes, and some types of cancer, as well as the usefulness of IF in reducing body weight and cardiovascular risk factors such as hypertension. Furthermore, we explored the cellular pathways targeted by IF to exert their beneficial effects by activating effector proteins that modulate cell functions and resistance to oxidative stress. In contrast, we investigated concerns regarding human health related to the adoption of IF dietary regimens, highlighting the profound debate surrounding weight loss regimens. We examined and compared several clinical trials to formulate an updated concept regarding IF and its therapeutic potential.
Keyphrases
- body weight
- metabolic syndrome
- cardiovascular risk factors
- insulin resistance
- weight loss
- type diabetes
- endothelial cells
- blood glucose
- cardiovascular disease
- glycemic control
- clinical trial
- oxidative stress
- blood pressure
- uric acid
- pluripotent stem cells
- signaling pathway
- adipose tissue
- induced pluripotent stem cells
- high intensity
- risk factors
- bariatric surgery
- papillary thyroid
- dna damage
- single cell
- cancer therapy
- skeletal muscle
- regulatory t cells
- magnetic resonance imaging
- dendritic cells
- physical activity
- computed tomography
- stem cells
- roux en y gastric bypass
- cell therapy
- electronic health record
- body mass index
- weight gain
- study protocol
- bone marrow
- drug induced
- heat stress
- lymph node metastasis
- mass spectrometry
- induced apoptosis
- phase ii
- drug delivery